Skip to Content
Guillain-Barré syndrome is a rare
nerve disorder that occurs when the body's own defenses (immune system) attack
part of the nervous system. For this reason, you may be treated with
immunotherapy, which is designed to alter or combat the abnormal immune
response by removing the antibodies that are attacking your body.
Two types of immunotherapy may be used to treat Guillain-Barré syndrome:
One of these treatments is often started immediately after
you have been diagnosed if you seem to be getting worse. Early treatment may
reduce your recovery time.
Plasma exchange and IVIG appear to be
equally effective when given early in the course of the disease. They also have
similar costs. The choice between one or the other treatment may depend on what
is available and most practical.
ByHealthwise StaffPrimary Medical ReviewerAnne C. Poinier, MD - Internal MedicineSpecialist Medical ReviewerColin Chalk, MD, CM, FRCPC - Neurology
Current as ofOctober 14, 2016
Current as of:
October 14, 2016
Anne C. Poinier, MD - Internal Medicine & Colin Chalk, MD, CM, FRCPC - Neurology
To learn more about Healthwise, visit Healthwise.org.
© 1995-2016 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
© Copyright 2017 Rush Copley Medical Center • 2000 Ogden Avenue; Aurora, IL 60504
Main: 630-978-6200 • Physician Referral & Information: 630-978-6700 or 866-4COPLEY (866-426-7539)